Pulling SEC filings + quote and writing the call…
TXG
10x Genomics, Inc.
Next earnings Aug 5, 2026 (after close) · consensus $-0.25 EPS, $148M rev
Last earnings -1.4% on 2026-05-07
$32.94
▼ -5.22%$32.94▲ +199.18%
over 1Y
L $10.56EODHDH $34.76
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-5.2%
1W+2.2%
1M+33.8%
3M+72.1%
YTD+98.2%
1Y+199.2%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 21 analysts
Buy
Revenue grew 5.2% YoY; but unprofitable (net margin -6.8%).
10x Genomics, Inc. shows $643M in FY2025 revenue (+5.2% YoY), a -6.8% net margin, and -5.5% ROE.
Sources: SEC EDGAR (CIK 0001770787, latest 10-Q filed 2026-05-08) · EODHD · as of 6/22/2026, 8:52:04 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.